Hydrogen sulphide: Diabetic cardiomyopathy as the paradigm of its pleiotropic function
- 22 June 2022
- journal article
- editorial
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 52 (9), e13823
- https://doi.org/10.1111/eci.13823
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Gases in Sepsis: Novel Mediators and Therapeutic TargetsInternational Journal of Molecular Sciences, 2022
- Association of sulfur content in erythrocytes with cardiovascular parameters and blood pressureClinical Hemorheology and Microcirculation, 2021
- An Updated Insight Into Molecular Mechanism of Hydrogen Sulfide in Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury Under DiabetesFrontiers in Pharmacology, 2021
- The Role of the Signaling Pathways Involved in the Protective Effect of Exogenous Hydrogen Sulfide on Myocardial Ischemia-Reperfusion InjuryFrontiers in Cell and Developmental Biology, 2021
- Plasma hydrogen sulfide: A biomarker of Alzheimer's disease and related dementiasAlzheimer's & Dementia, 2021
- H2S donor improves heart function and vascular relaxation in diabetesEuropean Journal of Clinical Investigation, 2020
- Hydrogen Sulfide as a Potential Alternative for the Treatment of Myocardial FibrosisOxidative Medicine and Cellular Longevity, 2020
- Low Plasma Hydrogen Sulfide Is Associated with Impaired Renal Function and Cardiac DysfunctionAmerican Journal of Nephrology, 2018
- The Role Of Microcirculatory Function And Plasma Biomarkers In Determining The Development Of Cardiovascular Adverse Events In Patients With Peripheral Arterial Disease: a 5 year follow upThe Anatolian Journal of Cardiology, 2018
- 2013 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2013